Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • E1/E2/E3 Enzyme
    (79)
  • Apoptosis
    (13)
  • Mdm2
    (11)
  • NF-κB
    (4)
  • NEDD8
    (3)
  • p53
    (3)
  • Bcl-2 Family
    (2)
  • Ligand for E3 Ligase
    (2)
  • Molecular Glues
    (2)
  • Others
    (2)
Filter
Search Result
Results for "

E1/E2/E3 Enzyme

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    81
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    2
    TargetMol | Compound_Libraries
  • Dye Reagents
    1
    TargetMol | Dye_Reagents
  • PROTAC Products
    8
    TargetMol | PROTAC
  • Natural Products
    5
    TargetMol | Natural_Products
  • Recombinant Protein
    9
    TargetMol | Recombinant_Protein
Pevonedistat
MLN4924
T6332905579-51-3
Pevonedistat (MLN4924) is a potent and selective NEDD8 activating enzyme (NAE) inhibitor (IC50=4.7 nM) with therapeutic potential for myelodysplastic syndromes (MDS) and antitumor activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Indole-3-carbinol
Indole-3-Methanol, I3C, 3-Indolemethanol
T2947700-06-1
Indole-3-carbinol (I3C), a naturally occurring, orally available cleavage product of the glucosinolate glucobrassicanin, inhibits NF-κB and IκBα kinase activation.
  • Inquiry Price
Size
QTY
ML-792
T161021644342-14-2
ML-792 is a specific small ubiquitin-like modifier activating enzyme (SUMO) inhibitor. ML-792 selectively inhibits SAE SUMO1 and SAE SUMO2 with IC50 of 3 and 11 nM.
  • Inquiry Price
Size
QTY
TAK-243
MLN7243
T169741450833-55-2
TAK-243 (MLN7243) is a selective inhibitor of the ubiquitin-activating enzyme UAE (IC50=1 nM), blocking ubiquitin binding and disrupting both mono-ubiquitin signaling and overall protein ubiquitination. TAK-243 exhibits antitumor activity and promotes apoptosis.
  • Inquiry Price
Size
QTY
2-D08
T7379144707-18-6
2-D08 is a synthetic flavone that inhibits sumoylation, also inhibits Axl with an IC50 of 0.49 nM.2-D08 showed anti-aggregatory and neuroprotective effect.
  • Inquiry Price
Size
QTY
Nutlin-3a
Nutlin-3a chiral, (−)-Nutlin-3, (-)-Nutlin-3
T6023675576-98-4
Nutlin-3a is the active enantiomer of Nutlin-3, an MDM2 antagonist that inhibits MDM2-p53 interaction (Ki=90 nM) and activates p53. Nutlin-3a binds preferentially to the p53-binding pocket of MDM2, leading to stabilization of p53 and activation of the p53 pathway. Nutlin-3a has antitumor activity.
  • Inquiry Price
Size
QTY
Skp2 inhibitor 2
T781942760612-77-7
Skp2 inhibitor 2 (14f) impedes the F-box protein S-phase kinase-associated protein 2 (Skp2), demonstrating an IC50 of 10.2 μM against Skp2-Cks1. This compound targets Skp2, a component of cullin-RING ligases that recruits and ubiquitinates substrates, playing roles in both proteolytic and non-proteolytic processes [1].
  • Inquiry Price
8-10 weeks
Size
QTY
TRAF6 peptide TFA
T78221
TRAF6 peptide TFA, a specific inhibitor of the TRAF6-p62 interaction, significantly inhibits NGF-dependent ubiquitination of TrkA. This peptide demonstrates promising research applications in various neurological disorders, including Alzheimer's disease (AD), Parkinson's, ALS, head trauma, epilepsy, and stroke [1].
  • Inquiry Price
7-10 days
Size
QTY
Smurf1-IN-1
T787211824708-03-3
Smurf1-IN-1, a selective E3 ubiquitin protein ligase 1 (SMURF1) inhibitor, exhibits oral activity with an IC50 of 92 nM and demonstrates considerable efficacy in a rat model of pulmonary hypertension [1].
  • Inquiry Price
6-8 weeks
Size
QTY
Cbl-b-IN-6
T798932815221-33-9
Cbl-b-IN-6 (Compound 246) is an inhibitor of casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl, with half-maximal inhibitory concentrations (IC50s) of 6.7 nM for Cbl-b and 5.2 nM for c-Cbl, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Cbl-b-IN-7
T798942815221-35-1
Cbl-b-IN-7 (Compound 248) is an inhibitor of casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl, with half-maximal inhibitory concentrations (IC50s) of 6.7 nM and 5.2 nM, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Cbl-b-IN-8
T798952815223-33-5
Cbl-b-IN-8 (Compound 293) is an inhibitor of casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl, with half maximal inhibitory concentrations (IC50s) of 5.5 nM and 7.8 nM, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Cbl-b-IN-9
T798962815223-41-5
Cbl-b-IN-9 (Compound 300) is a potent inhibitor targeting casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl, with half-maximal inhibitory concentrations (IC50s) of 5.6 nM and 4.7 nM, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Cbl-b-IN-10
T798972815225-12-6
Cbl-b-IN-10 (Compound 463) is a potent inhibitor of both casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl, with half-maximal inhibitory concentrations (IC50s) of 6.0 nM and 3.5 nM, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Cbl-b-IN-11
T798982815225-15-9
Cbl-b-IN-11 (Compound 466) is an inhibitor of casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl, with half-maximal inhibitory concentrations (IC50s) of 6.4 nM and 6.1 nM, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Cbl-b-IN-12
T798992851871-29-7
Cbl-b-IN-12 (Example 10) is a CBL-B inhibitor with an IC50 of less than 100 nM [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Cbl-b-IN-13
T799002368841-85-2
Cbl-b-IN-13 (Example 520) is a potent Cbl-b inhibitor with an IC50 of less than 100 nM, capable of activating T-cells [1].
  • Inquiry Price
8-10 weeks
Size
QTY
RNF5 agonist 1
T20351669909-92-8
RNF5 agonist 1 (analog-1), a structural analog of the RNF5 inhibitor inh-02, is a potent RNF5 agonist. In CFBE41o- cells expressing F508del-CFTR, RNF5 agonist 1 enhances the ubiquitination of ATG4B.
  • Inquiry Price
Size
QTY
HGC652
T2046703055558-98-7
HGC652 is a molecular glue that targets the E3 ubiquitin ligase TRIM21, facilitating the formation of a ternary complex between TRIM21 and NUP98, which induces the degradation of NUP155 and nuclear pore complex proteins, ultimately leading to cell death. HGC652 inhibits the proliferation of various cancer cells, with its antiproliferative activity depending on the expression level of TRIM21.
  • Inquiry Price
Size
QTY
Ethanolamine-Thalidomide-4-OH
T2052791957235-61-8
Ethanolamine-Thalidomide-4-OH is an E3 ligase ligand-linker conjugate used in the synthesis of PROTACs, such as [PROTAC BTK Degrader-13].
  • Inquiry Price
Size
QTY
PRC1-IN-1
T2053062396639-29-3
PRC1-IN-1 (compound RB-4) is an inhibitor of the polycomb repressive complex 1 (PRC1) with an IC50 of 2.3 μM. It targets RING1B-BMI1, RING1A-BMI1, and RING1B-PCGF1, exhibiting IC50 values of 2.8 μM, 2.6 μM, and 1.8 μM, respectively.
  • Inquiry Price
10-14 weeks
Size
QTY
Mezigdomide
CC-92480
T107032259648-80-9In house
Mezigdomide (CC-92480) is a potent, novel, selective and active cereblon E3 ubiquitin ligase modulator (CELMoD) that acts as a molecular glue. Mezigdomide has anti-myeloma activity. [1]
  • Inquiry Price
6-8 weeks
Size
QTY
Cbl-b-IN-3
T637902573775-59-2In house
Cbl-b-IN-3 is a potent inhibitor of casitas b lineage lymphoma proto-oncogene-b (Cbl-b) (ic50 < 1 nM).
  • Inquiry Price
10-14weeks
Size
QTY
SAR405838
MI-77301, MI-773, MI773, MI 773
T65851303607-60-4In house
MI-773 (SAR405838 (MI 773)) is an orally available MDM2 antagonist with Ki of 0.88 nM. Phase 1.
  • Inquiry Price
4-6 weeks
Size
QTY